Navigation Links
Concentric Medical Completes Enrollment in Prospective Multi Center Stentriever™ Trial for Mechanical Thrombectomy in Stroke
Date:9/8/2011

MOUNTAIN VIEW, Calif., Sept. 8, 2011 /PRNewswire/ -- Concentric Medical, Inc., a global leader in acute ischemic stroke intervention, today announced completion of enrollment of the TREVO Study.  The TREVO Study (Thrombectomy REvascularization of large Vessel Occlusions in acute ischemic stroke) is the first evaluation of Stentriever™ technology in a European, multicenter, prospective clinical trial.  The TREVO Study was designed to assess the ability of the Trevo® System to remove the blood clots that cause strokes and to restore blood flow to the brain.

The TREVO Study employed the latest generation of the Trevo® Retrieval System and the preliminary results are very promising. Interim data from the study were presented in May at the European Stroke Congress by Professor Olav Jansen, Head of Neuroradiology at Universitatsklinikum Schleswig-Holstein Kiel.  The interim revascularization rate in the first 36 patients was 96%. Thirty patients had 90-day follow up and 63% of these had a good outcome.  A "good outcome" was defined as being functionally independent at 90 days (modified Rankin score of 2 or less).

Professor Olav Jansen and Professor Nils Wahlgren, Professor of Neurology at Karolinska University Hospital, are co-Principal Investigators of the Study. Professor Wahlgren commented: "The TREVO study represents an important step forward in the evidence supporting the treatment of patients with moderate and severe strokes with mechanical thrombectomy devices, such as the Trevo System. The rigorous conduct of this prospective multicenter trial provides more confidence not only in patient selection, but in the successful procedural and clinical outcomes for these patients."

"The Trevo System is the first device of this type designed specifically for removal of the clot in ischemic stroke patients.  Not only was it easy to use, but the architectur
'/>"/>

SOURCE Concentric Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Concentric Medical to Sponsor Randomized Trial
2. Concentric Medical and the Merci Retrieval System(R) Highlighted at the 2010 International Stroke Conference
3. Concentric Medical Announces Product and Procedure Reimbursement as Well as Full Commercialization of the Merci Retriever® in Japan
4. Concentric Medical Announces Commercial Launch of Trevo™ in Europe
5. Concentric Medical Announces First Stroke Patients Treated in Canada with Trevo™ System
6. Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial
7. Concentric Medical Launches Full Family of Merci Retrievers® in Japan
8. Concentric Medical Launches DAC® 070, A New Distal Access Catheter
9. STRYKER Signs Definitive Agreement to Acquire CONCENTRIC MEDICAL, Inc.
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Boehringer Ingelheim will ... disease at the American Thoracic Society International Conference ... , May 17 – 22. Data ... for the treatment of chronic obstructive pulmonary disease ... well as investigational compounds for asthma, idiopathic pulmonary ...
(Date:5/17/2013)... 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 inhibitor ... both dose groups. The primary endpoint assessed the proportion ... with data reported in previous trials, the most common ... results will be presented at an upcoming medical congress. ...
(Date:5/17/2013)... NATICK, Mass. , May 17, 2013  Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
(Date:5/19/2013)... foodies everywhere have long recognized ginger as a great ... sweet and savory dishes; now, a study from researchers ... root also may have properties that help asthma patients ... will be presented at the ATS 2013 International Conference. ... the bronchial tubes that carry air into and out ...
(Date:5/19/2013)... People in Minnesota have a great option ... offering its 28 Day Fat Loss Formula. The best ... of their own home. The product sells for $135 dollars ... be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is ... now, but after using the 28 Day Fat Loss Formula ...
(Date:5/19/2013)... 19, 2013 Today, Zane Benefits, ... business health insurance . Zane Benefits, which provides ... health benefits, is the leader in health care ... reimbursement arrangements . , According to Zane Benefits’ ... intrinsically know the value of small business health ...
(Date:5/19/2013)... These molecular diagnostics market reports provide ... Italy, Germany and France:,     Major ... as well as key economic, regulatory, demographic, social ... the next five years. ,     An extensive ... formats, detection methodologies, trends in testing automation and ...
(Date:5/19/2013)... Americans live closer to their dogs than ... Medical Association (AVMA) U.S. Pet Ownership and Demographics Sourcebook, ... dog a member of the family, up from the ... years earlier. , According to the American Pet Products ... dedicated to pets has increased every year without interruption, ...
Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3
... May 20 - XanGo, LLC, the mangosteen beverage category ... icon, former presidential advisor, philanthropist and motivational speaker Doug ... brings to XanGo deep experience in direct selling, having ... the past 30 years. He previously served as special ...
... WILL BE SOLD ON iTUNES TO RAISE FUNDS FOR ... Will Be Donated To D.C.-Based Accelerate Brain Cancer CureLOS ... the seventh season of "American Idol," David Cook returns ... Wednesday night to perform "Permanent," -- a song he ...
... WINNIPEG, May 20 /PRNewswire/ - The Children,s Hospital ... on its newly commissioned RIVA System (Robotic Intravenous ... syringes and bags from Intelligent Hospital Systems (IH ... The Children,s Hospital of Philadelphia was rated first ...
... RALEIGH, N.C. , May 20 ... healthcare grade televisions and on-demand patient and staff interactive ... on-demand video education and entertainment system into ... expanded and renovated its facility, adding two new floors ...
... May 1st, 2009 in TEDA Tianjin, ChinaTEDA Tianjin, China, ... contract manufacturer of API,s and intermediates, and Drug Products ... opening if its high potency Active Pharmaceutical Ingredient (API) ... This dedicated facility is sited at Asymchem,s TEDA Tianjin ...
... and Healthcare Industry Leaders to Measure Impact of Patient ... A group of prominent healthcare leaders, clinicians, researchers ... Institute for Interactive Patient Care (IIPC). ... for the importance of patient engagement as a means ...
Cached Medicine News:Health News:Direct Selling Icon, Former Presidential Advisor Doug Wead Joins XanGo 2Health News:Direct Selling Icon, Former Presidential Advisor Doug Wead Joins XanGo 3Health News:David Cook to Perform 'Permanent' on the American Idol Season Finale Tonight 2Health News:TeleHealth Services Chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 2Health News:TeleHealth Services Chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 3Health News:TeleHealth Services Chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 4Health News:Asymchem Announces Opening of High Potency API and Drug Product Facility 2Health News:Institute for Interactive Patient Care Launched 2Health News:Institute for Interactive Patient Care Launched 3Health News:Institute for Interactive Patient Care Launched 4
... the advantages of the IPL Quantum DL and ... and other deeper vascular lesions. This cost-effective system ... alone device or as an upgrade to the ... range of conditions including: Leg veins ...
... powerful, versatile, and innovative aesthetic treatments to ... Light and Laser System.,With StarLux you attach ... so theres no need to buy ... choose among Laser, Intense Pulsed Light, and ...
... (Western Blot): The assay uses immortalized human ... surface. The cells are fixed to the ... uninfected T-cells are provided as a control. ... HIV- I antibodies comes in contact with ...
... say the most efficient,aspiration is ... movement of the,cannula tip. Rigorous ... ARC-H II Reciprocating Cannula,assures that ... is,restricted to a longitudinal axis ...
Medicine Products: